Ascidian Therapeutics

View the org chart displaying its 14 main executives

Most searched biographies at Ascidian Therapeutics

• Michael Ehlers, Chairman of the Board, Interim President and Chief...
• Arthur Levin, Independent Director
• Anna Batarina, Director

Popular executive movements at Ascidian Therapeutics

• Michael Ehlers, who was Chairman of the Board, is promoted to Chairman of the Board, Interim President and Chief Executive Officer  (posted on November 9 2023).
• Romesh Subramanian, President & Chief Executive Officer, has left the company  (posted on November 9 2023).

Create your alert
to follow the executive moves at Ascidian Therapeutics.

Ascidian Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Ascidian Therapeutics

Social media about Ascidian Therapeutics

• Ascidian Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ascidian Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Michael Ehlers

Call Ascidian Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error